Apnimed, Inc. (APMD) director reports major equity reclassification and option changes

Apnimed, Inc. director Lawrence G. Miller reported significant equity reclassification and option changes on August 3, 2026. These transactions included the conversion of Series A Preferred Stock into Common Stock and the reclassification of Class A Common Stock into Common Stock, consistent with the company's IPO. Miller also reported numerous paired transactions where existing options and shares were disposed of and identical amounts of Common Stock options or shares were acquired, at various exercise prices and vesting schedules.